Oncology is witnessing a paradigm shift with the advent of targeted therapies, ushering in an era of precision medicine. These innovative therapies focus on identifying and exploiting specific molecular vulnerabilities within cancer cells, thereby minimizing harm to healthy tissues. By tailoring treatment regimens based on the unique genetic makeup